• Mon news: Novartis Kisqali breast cancer trial. ESMO news: Bayer, Bristol Myers, Regeneron and more. Biosecure Act fallout. Boston Scientific/Silk Road merger. See more on our front page

Biosurgery Division Manager





I'd seriously be looking into the ESC managers name in the area as that merger is imminent. They are not going to keep a bio DM that has 1 maybe 2 reps in a city vs an ESC manager that already has 5-6. Besides Biosurgery has gone down the shi++er the past few years. I looked at moving over there about 4 years ago, but since then in my area alone there has been 3 reps come and go. The turnover there makes the 3 year tenure average at ESC look incredible.